K. Matta

Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies

D. Brander, Joseph O. Moore, J. Gockerman, 2014, Leukemia & lymphoma.

The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms.

J. Klingensmith, Murim Choi, R. Stottmann, 2006, Developmental biology.

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.

M. Vitek, Joseph O. Moore, J. Gockerman, 2011, Blood.

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

T. Tedder, G. Venturi, T. Matsushita, 2013, Leukemia.

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia

M. Datto, C. Rehder, C. Decastro, 2012, Leukemia & lymphoma.